Kang Yuan Pharmaceuticals (600557.SH): Qihuang Zhengqi Granules approved for clinical trials.

Zhtng Financial APP News, Kangyuan Pharmaceutical (600557.SH) announced that the company recently received the Drug Clinical Trial Approval Notification issued by the National Medical Products Administration for its Astragalus and Yellow Qi Granules, approving the clinical trial for cancer-related fatigue. Astragalus and Yellow Qi Granules are a clinical experience formula formed under the guidance of traditional Chinese medicine theory, with the efficacy of nourishing Qi and blood, and replenishing deficiencies.